A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation

Hepatitis B virus (HBV) reactivation reportedly occurs frequently after hematopoietic stem cell transplantation (HSCT) in resolved HBV-infected patients. Here, 50 patients with resolved HBV infections and scheduled to undergo HSCT were enrolled; all subjects were vaccinated with three doses of hepat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Koji, Kimura, Kiminori, Kanda, Yoshinobu, Sugiyama, Masaya, Kakihana, Kazuhiko, Doki, Noriko, Ohashi, Kazuteru, Bae, Sung Kwan, Takahashi, Kazuhiro, Ishihara, Yuko, Mizuno, Ishikazu, Onishi, Yasushi, Onozawa, Masahiro, Onizuka, Makoto, Yamamoto, Masahide, Ishikawa, Tetsuya, Inoue, Kazuaki, Kusumoto, Shigeru, Hashino, Satoshi, Saito, Hidetsugu, Kanto, Tatsuya, Sakamaki, Hisashi, Mizokami, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329632/
https://www.ncbi.nlm.nih.gov/pubmed/32071416
http://dx.doi.org/10.1038/s41409-020-0833-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329632/
https://www.ncbi.nlm.nih.gov/pubmed/32071416
http://dx.doi.org/10.1038/s41409-020-0833-5

Ejemplares similares